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EDITORIAL COMMENT
Valve Surgery in the Elderly
A Question of Quality (of Life)?*
John S. Rumsfeld, MD, PHD, FACC
Denver, Colorado
Over the next two decades, the aging of the population will
force a major shift in clinical care in the U.S. By 2010, over
40 million Americans will be age 65 years and older, 18
million Americans will be over the age of 75 years, and the
burden of cardiac disease among older persons will continue
to rise (1,2). Clinicians caring for patients with cardiovas-
cular disease will need to make tough decisions about the
use of therapies and interventions in older persons. This will
be a tremendous challenge for multiple reasons. First, older
age is an independent risk factor for higher mortality and
morbidity in cardiac populations (3). Second, elderly pa-
tients have a heavy burden of comorbid diseases, which
complicates management and further increase the risk of
adverse outcomes (4,5). Third, the evidence base for most
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cardiovascular therapies stems from clinical trials that have
excluded elderly patients (particularly those 75 years of
age), leaving clinicians with relatively little direct evidence
to guide treatment (3,6). And finally, few studies have
focused on patient-centered outcomes, including health-
related quality of life (HRQL). Ultimately, for clinicians to
make the best decisions about cardiovascular therapies, a
clear understanding of the impact of these therapies on the
HRQL of patients is essential. This is particularly true for
elderly patients because many older persons express a
preference for quality of life over quantity of life, and
survival benefits may not be the primary therapeutic goal
(7).
Cardiac valve surgery is an excellent example where
HRQL considerations are critical, but where evidence is
lacking. Valve surgery is increasingly performed on older
patients, including those over 75 years (6,8). At the same
time, advanced age is a risk factor for operative mortality
with valve surgery (6,8,9). While data is limited, studies of
valve surgery in octogenarians have reported short-term
(e.g., 30-day) mortality rates of approximately 8% to 20%,
with lower mortality for isolated aortic valve surgery and
higher mortality for mitral valve, multiple valve, and valve-
coronary artery bypass graft (CABG) operations (6,8,10–
12). Very limited data on valve surgery on nonagenarians
suggests operative mortality in excess of 15% (13). Clearly,
the elevated operative mortality risk in older persons under-
going valve surgery must be balanced against the potential
benefits of the operation.
A principal goal of cardiac valve surgery is improvement
in HRQL through reduction of symptoms and better
physical function. Although valve surgery will be under-
taken in select elderly patients for potential survival benefit
(e.g., isolated severe aortic stenosis in a patient without
significant comorbidities), the primary goal of the operation
for most elderly persons should be improvement in HRQL.
Unfortunately, the potential HRQL benefits of the opera-
tion may be offset in older patients by neurocognitive
deficits after surgery, increased short- and long-term com-
plications, and incomplete recovery resulting in significant
residual functional limitations (6). Coupled with the tech-
nical challenges of valve surgery in older persons, including
the potential for extensive calcification of the aortic valve,
annulus, and aortic root, and the prevalence of ischemic
mitral regurgitation, it cannot be assumed that surgery to
correct valvular pathology will improve HRQL. Without
evidence supporting HRQL benefits of valve surgery in the
elderly, clinicians are faced with the decision of recom-
mending an intervention for which the risks may outweigh
the potential gains.
In this issue of the Journal, Sedrakyan et al. (14) evaluated
whether older age attenuates the HRQL benefits of cardiac
valve surgery in a cohort of 220 patients undergoing aortic
or mitral valve operations. They measured HRQL at base-
line and 18 months after the operation using the Short-
Form 36 (SF-36) health status survey. The SF-36 does not
contain disease-specific questions (i.e., there are no ques-
tions directly relating to symptoms or functional limitations
from valve disease), but is a widely validated measure of
overall physical and mental health status (15). The authors
found clinically significant mean improvements in overall
physical and mental health status for patients in the 65-,
65- to 74-, and 75-year-old age groups. The average
improvements in SF-36 scores were similar across the age
spectrum and for both aortic and mitral valve operations.
Remarkably, postoperative SF-36 scores were restored to
population norms for all age groups. Therefore, the authors
concluded that age does not appear to limit the HRQL
benefits of valve surgery.
Several limitations of the Seredkyan et al. (14) study
should be noted. First, the study was performed at a single
tertiary care center, which may limit generalizability. Sec-
ond, over one-third of the patients had combined valve-
CABG procedures, so the relative HRQL improvement due
to repair of the valve lesion versus coronary revascularization
cannot be determined. Finally, the baseline HRQL assess-
ment was administered after surgery, raising some concern
of bias. It is possible that patients who have survived a
cardiac operation would overstate their preoperative HRQL
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deficits, leading to an overestimation of the improvement in
HRQL after the operation. Furthermore, this study design
leads to the exclusion of patients with early deaths and those
that were too ill or cognitively impaired after the operation
to participate. This may result in a study cohort largely
composed of patients who benefited from the procedure.
Nonetheless, the results of this study are consistent with
previous studies that have examined HRQL after valve
surgery in the elderly (10–12,16–18). Furthermore, the
current study avoids many of the limitations of previous
studies, such as very small sample sizes, short follow-up,
failure to use validated HRQL measures, and/or failure to
assess HRQL longitudinally. The study by Seredkyn et al.
(14), therefore, moves us toward a better understanding of
the impact of valve surgery on HRQL.
The primary implication of the study by Sedrakyan et al.
(14) is that older patients undergoing cardiac valve surgery
can have significant improvements in HRQL, on par with
improvements seen in younger patients. It is essential to
recognize, however, that the average HRQL improvements
reported in this study will not be realized in all patients
undergoing the operation. More importantly, the study does
not tell us which elderly patients should be chosen for the
operation. The decision to recommend valve surgery for a
given older patient will need to be individualized based on
the specific valvular pathology and severity, the actual age of
the patient (because the term “elderly” remains a broad
concept), associated comorbid diseases, and patient prefer-
ences regarding the potential risks and benefits of the
operation. It will be essential to supplement this decision-
making with an understanding of which patients are most
likely to derive an HRQL benefit from the operation.
Therefore, the study by Sedrakyan et al. (14) should be
viewed as an important first step toward a greater under-
standing of how to choose cardiac therapies to optimize
patient-centered outcomes. To achieve this goal, expanded
research efforts are needed to measure the impact of cardiac
therapies on the HRQL of older cardiovascular patients.
Studies are also needed to identify the determinants of
HRQL in cardiac populations and to evaluate interventions
to improve patient-centered outcomes. Ideally, new clinical
trials will be undertaken, such as the recently published
Trial of Invasive versus Medical therapy in Elderly patients
(TIME) (19). In many instances, however, new clinical
trials are not likely to be forthcoming, and we must rely on
careful observational studies like the one by Seredkyn et al.
(14). Registries are a potentially rich source of data for
observational studies, and there are several well-established
registries for cardiac surgery (20). However, a key deficiency
of existing cardiovascular registries is the lack of data on
patient-centered outcomes. The time has come for HRQL
measures to be incorporated in all cardiovascular clinical
trials, observational studies, and cardiovascular registries.
Although further research is critical, we can gain some
insight from the existing literature on how HRQL measures
may be helpful in clinical decision-making. It has been
shown in multiple cardiac populations that HRQL inde-
pendently predicts subsequent mortality (21–23). This has
not yet been evaluated for valve surgery, but we can
anticipate that patients with diminished preoperative
HRQL will be at higher risk for operative mortality. On the
other hand, it is likely that only those patients with
significant HRQL deficits will derive HRQL benefits with
the operation (24). This paradox is directly analogous to
patients with reduced left ventricular ejection fraction, who
are at increased risk for CABG surgery, but can derive a
greater survival benefit (25). Thus, clinicians should strongly
consider formal measurement of HRQL before cardiac
valve surgery to aid in risk stratification.
In conclusion, cardiovascular clinicians will increasingly
be faced with the challenges of decision-making in elderly
patients. The issues prominent in the growing field of
“geriatric cardiology” are moving into mainstream cardiol-
ogy. An understanding of the impact of therapies on the
HRQL of older cardiac patients, and an understanding of
how HRQL data can be used in the clinical management of
elderly patients, will be critical. Only through dedicated
research and clinical practice efforts will we be ready to make
decisions in elderly patients that will optimize patient-
centered outcomes, and, ultimately, provide the highest
quality of care.
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